|
2024
|
Invention
|
Compositions and methods for modulating delta gamma chain mediated immunity.
Provided herein, in... |
|
|
Invention
|
Methods for site specific conjugation of proteins containing glycosylated fc domains.
Provided h... |
|
|
Invention
|
Safe and effective method of treating psoriasis with anti-il23 specific antibody.
A method of tr... |
|
|
Invention
|
Methods of treating crohn's disease with anti-il23 specific antibody.
A method of treating Crohn... |
|
|
Invention
|
Synthetic genetic elements for biomanufacture.
Recombinant constructs, cells and means for impro... |
|
|
Invention
|
Radiolabeling of polypeptides.
Improved methods of radiolabeling antibodies using click chemistr... |
|
|
Invention
|
Drug delivery device. In one example, a drug delivery system, such as an on-body or off-body deli... |
|
|
Invention
|
Methods for treating multiple myeloma. Embodiments of the present invention relate to methods of ... |
|
|
Invention
|
Methods for treatment of non-small cell lung cancer (nsclc). The present disclosure provides meth... |
|
|
Invention
|
Vaccines based on mutant calr and jak2 and their uses.
Provided are vaccines, polypeptides and p... |
|
|
Invention
|
Pharmaceutical compositions comprising a bispecific bcma/cd3 antibody at high concentration.
Pro... |
|
|
Invention
|
Pharmaceutical compositions comprising a bispecific bcma/cd3 antibody at high concentration. Prov... |
|
|
Invention
|
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases.
The ... |
|
|
Invention
|
Methods of treating cancers and enhancing efficacy of t cell redirecting therapeutics.
Disclosed... |
|
|
Invention
|
Method of treating ulcerative colitis with a combination of antibodies to il-23 and tnf alpha. A ... |
|
|
Invention
|
Method of treating crohn's disease with a combination of antibodies to il-23 and tnf alpha. A met... |
|
|
Invention
|
Methods for treating multiple myeloma.
Embodiments of the present invention relate to methods of... |
|
|
Invention
|
Materials and methods for the manufacture of pluripotent stem cells.
Provided here in are method... |
|
|
Invention
|
Differentiation of human embryonic stem cells into pancreatic endocrine cells using hb9 regulator... |
|
|
Invention
|
Use of approved bispecific egfr and met specific antibody drug product to treat non-small cell lu... |
|
|
Invention
|
Combination therapies with bi-specific anti-egfr/c-met antibodies and anti-pd-1 antibodies. The p... |
|
|
Invention
|
Smart label devices, systems, and methods.
The subject disclosure relates to systems, methods, a... |
|
|
Invention
|
Bcma-targeted car-t cell therapy for multiple myeloma.
Provided herein are methods of treating a... |
|
|
Invention
|
Compositions comprising a bispecific gprc5d/cd3 antibody.
Provided herein are aqueous pharmaceut... |
|
|
Invention
|
Compositions comprising a bispecific gprc5d/cd3 antibody. Provided herein are aqueous pharmaceuti... |
|
|
Invention
|
Macrocyclic aminopyridine compounds as egfr inhibitors. The present invention provides novel macr... |
|
|
Invention
|
Methods for treating multiple myeloma.
Methods of treating cancers using a BCMA×CD3 bispecific a... |
|
|
Invention
|
Cd8a-binding fibronectin type iii domains.
Fibronectin type III domains (FN3) that specifically ... |
|
|
Invention
|
Compositions comprising a t cell redirection therapeutic and a vla-4 adhesion pathway inhibitor. ... |
|
|
Invention
|
Manufacturing methods for producing anti-il12/il23 antibody compositions.
Methods of manufacture... |
|
|
Invention
|
Generation of human pluripotent stem cell derived functional beta cells showing a glucose-depende... |
|
|
Invention
|
Safe and effective method of treating ulcerative colitis with anti-il12/il23 antibody.
Described... |
|
2023
|
Invention
|
Anti- gprc5d antibodies, bispecific antigen binding molecules that bind gprc5d and cd3, and uses ... |
|
|
Invention
|
Bcma-targeted car-t cell therapy for multiple myeloma. Provided herein are methods of treating a ... |
|
|
Invention
|
Use of anti-egfr/anti-met antibody to treat gastric or esophageal cancer.
The present disclosure... |
|
2022
|
Invention
|
Cd33 x vd2 multispecific antibodies for the treatment of cancer.
The invention relates to multis... |
|
|
Invention
|
Anti-vegfr1 antibodies and their uses.
Disclosed herein are antibodies or antigen binding fragme... |
|
|
Invention
|
Peptide inhibitors of interleukin-23 receptor.
The present invention relates to novel cyclic pep... |
|
|
Invention
|
Bicyclic peptide inhibitors of interleukin-23 receptor.
The present invention relates to novel b... |
|
|
Invention
|
Predictive cell-based fed-batch process.
Methods and systems related to delivery of complex feed... |
|
|
Invention
|
Materials and methods for enhanced stem-cell like memory t cell engineering.
The present disclos... |
|
2021
|
Invention
|
Materials and methods for binding siglec-3/cd33.
The invention provides antigen binding domains ... |
|
2019
|
P/S
|
Operating an online-marketplace featuring cell and gene therapy treatments and services; business... |
|
2016
|
P/S
|
Software as a service (SAAS) services, namely, hosting software for use by others for ordering, t... |
|
2008
|
P/S
|
Pharmaceutical and veterinary preparations, pharmaceutical preparations for the prevention and tr... |
|
2007
|
P/S
|
patient assistance program, namely, financial assistance for patients receiving pharmaceutical pr... |
|
2003
|
P/S
|
Pharmaceutical for the treatment of autoimmune diseases and autoimmune disorders. |
|
2002
|
P/S
|
pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders |
|
2001
|
P/S
|
Medical device used to infuse pharmaceuticals. |
|
|
P/S
|
Pharmaceutical for treatment of autoimmune diseases and disorders. |
|
1998
|
P/S
|
Pharmaceutical and medical preparations and substances; pharmaceutical compositions for the treat... |
|
|
P/S
|
Pharmaceutical compositions for treatment of autoimmune diseases and disorders. |
|
|
P/S
|
Pharmaceutical compositions for treatment of autoimmune diseases and disorders |
|
1996
|
P/S
|
Pharmaceutical preparations and products. |
|
1994
|
P/S
|
Pharmaceutical preparations for prevention and treatment of disease of the circulatory system. |
|
|
P/S
|
pharmaceutical preparations for the prevention and treatment of diseases of the circulatory system |
